Quick Answer
AbCellera Biologics Inc. reported Net Income of -$146.41 million for fiscal year 2025.
AbCellera Biologics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$146.41M | +10.1% |
| 2024 | -$162.86M | -11.2% |
| 2023 | -$146.40M | -192.4% |
| 2022 | $158.52M | +3.3% |
| 2021 | $153.46M | +29.1% |
| 2020 | $118.92M | +5478.5% |
| 2019 | -$2.21M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$57.12M | -11.8% | -64.5% |
| June 30, 2025 | -$34.73M | +6.0% | +23.9% |
| March 31, 2025 | -$45.62M | -12.3% | +10.7% |
| September 30, 2024 | -$51.11M | -78.6% | -38.4% |
| June 30, 2024 | -$36.93M | -21.0% | +9.1% |
| March 31, 2024 | -$40.61M | -1.2% | -41.9% |
| September 30, 2023 | -$28.61M | -207.5% | +6.3% |
| June 30, 2023 | -$30.53M | -349.9% | +23.9% |
- AbCellera Biologics Inc. showed an increase of +10.1% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, AbCellera Biologics Inc.’s net income has declined by 6522.0% (from -$2.21 million to -$146.41 million).
- The most recent figure is from AbCellera Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: